European Pharmaceutical Pricing & Reimbursement

Oct. 3, 2012 - PRLog -- This event offers a unique platform for attendees to develop their knowledge in the field, make connections and explore new ideas in pricing and market access. The 2012 agenda will showcase solutions and strategies within key issues such as market access strategies, recent developments in the healthcare landscape and challenges in VBP and the effects of the AMNOG.  

Key Highlights of the Programme:

• Hear from experts in the field on Value Based Pricing: Principles and practice
• Debate EU policy challenges in access to medicines in Europe with experts from Germany, Italy, UK, Switzerland and Belgium
• Analyse market access strategies in Russia and Eastern Europe
• Learn about the latest regulations within pricing and reimbursement from industry
• Understand the facts and consequences of Germany’s AMNOG
• Discover the value of collaboration in HTA and managed entry schemes
• Consider an international view with perspectives from the Asia-Pac Region and North America

Visit our website here to register: www.smi-online.co.uk/2012europricing46.asp

Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184
or email on fbegum@smi-online.co.uk